Novo Nordisk | NVO - 税前利润

股票价格

36.83

每天变化

-0.20 -0.54%

每月一次

-7.07%

每年

-52.07%

Q1 预测

34.66

金融业

DKK

DKK 76.18B

现金及等价物

DKK 38.94B

DKK 1.95B

DKK 25.71B

DKK 32.79B

DKK 118.72B

股息收益率

DKK 3.11

DKK 5.18B

DKK 31.44B

DKK 54.39K

EPS每股收益

DKK 1.02

股本和储备

DKK 26.56B

DKK 64.01B

债务利息支出

DKK 82.1M

DKK 3.43B

DKK 14.02B

DKK 125.69B

DKK 4.03B

DKK 6.5B

DKK 5.18B

普通股股本

DKK 4.44B

13.93

DKK 25.52B

DKK 12.53B

销售和管理费用

DKK 2.86B

DKK 42.85B

贸易债权人

DKK 4.46B

应收帐款人

DKK 14.27B

	税前利润	更改		日
ANI Pharmaceuticals	USD 49.52M		39M	2025-09
Aurora Cannabis	CAD -1.58M		48.55M	2025-12
Bausch Health Companies	USD 218M		78M	2025-09
Bristol-Myers Squibb	USD 3.11B		1.34B	2025-09
Canopy Growth	CAD -62.26M		60.84M	2025-12
Corcept Therapeutics	USD 15.24M		16.45M	2025-09
Drreddys Laboratories	INR 15.43B		1.96B	2025-12
Eli Lilly	USD 7.23B		456M	2025-09
GlaxoSmithKline	GBP 1.23B		1.23B	2025-12
Merck	USD 6.74B		22M	2025-09
Nektar Therapeutics	USD -37.05M		15.27M	2024-09
Novartis	USD 4.64B		445M	2025-12
Novo Nordisk	DKK 33.8B		3.23B	2025-06
Novo Nordisk	DKK 25.52B		8.29B	2025-09
Pacira	USD 9.52M		11.45M	2025-09
Perrigo	USD 22.4M		19.2M	2025-09
Phibro Animal Health	USD 38.62M		1.26M	2025-12
Prestige Brands	USD 69.13M		7.35M	2025-09
Sanofi	EUR -1.16B		5.5B	2025-12
Supernus Pharmaceuticals	USD -1.91M		56.04M	2025-12
Zoetis	USD 887M		15M	2025-09